International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 1 , Pages 42-49 , 1 September 2010

A Phase I/II Trial of Gefitinib Given Concurrently With Radiotherapy in Patients With Nonmetastatic Prostate Cancer

  • Greetta Joensuu, B.M.

      Affiliations

    • Cancer Gene Therapy Group, Molecular Cancer Biology Program and Transplantation Laboratory and Haartman Institute and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
    • International Comprehensive Cancer Center Docrates, Helsinki, Finland
    • ,
  • Timo Joensuu, M.D., Ph.D.

      Affiliations

    • International Comprehensive Cancer Center Docrates, Helsinki, Finland
    • ,
  • Petri Nokisalmi, M.Sc., B.M.

      Affiliations

    • Cancer Gene Therapy Group, Molecular Cancer Biology Program and Transplantation Laboratory and Haartman Institute and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
    • HUSLAB, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Chandana Reddy, M.Sc.

      Affiliations

    • Radiation Oncology, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Jorma Isola, M.D., Ph.D.

      Affiliations

    • Institute of Medical Technology, University of Tampere, Tampere, Finland
    • ,
  • Mirja Ruutu, M.D., Ph.D.

      Affiliations

    • Department of Urology, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Mauri Kouri, M.D., Ph.D.

      Affiliations

    • International Comprehensive Cancer Center Docrates, Helsinki, Finland
    • ,
  • Patrick A. Kupelian, M.D.

      Affiliations

    • Department of Radiation Oncology, M. D. Anderson Cancer Center Orlando, Orlando, Florida
    • ,
  • Juhani Collan, M.D.

      Affiliations

    • Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Sari Pesonen, Ph.D.

      Affiliations

    • Cancer Gene Therapy Group, Molecular Cancer Biology Program and Transplantation Laboratory and Haartman Institute and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
    • HUSLAB, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Akseli Hemminki, M.D., Ph.D.

      Affiliations

    • Cancer Gene Therapy Group, Molecular Cancer Biology Program and Transplantation Laboratory and Haartman Institute and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
    • HUSLAB, Helsinki University Central Hospital, Helsinki, Finland
    • Corresponding Author InformationReprint requests to: Akseli Hemminki, Biomedicum, PO Box 63, 00014 University of Helsinki, Finland. Tel: (+358) 9 191 25 464; Fax: (+358) 9 1912 5465

Received 31 March 2009 ,Revised 20 July 2009 ,Accepted 22 July 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Greetta Joensuu and Timo Joensuu contributed equally to this work.

 This study was supported by AstraZeneca, HUCH Research Funds (EVO), Finnish Cancer Society, Sigrid Juselius Foundation, Academy of Finland, Biocentrum Helsinki and University of Helsinki.

 Conflict of interest: none.

PII: S0360-3016(09)02918-6

doi: 10.1016/j.ijrobp.2009.07.1731

International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 1 , Pages 42-49 , 1 September 2010

Article Tools

* Image Usage & Resolution